HCP Connect Clinical Author
Dr. Rahul Verma
Oncology
Specialty
Oncology
Clinical Updates
28
Experience
5 Years
Author Biography
About Dr. Rahul Verma
Dr. Rahul Verma is a medical oncologist with 5 years of experience in the systemic treatment of solid tumours. He earned his DM in Medical Oncology after an MD in General Medicine and works closely with targeted therapy and immunotherapy protocols. He follows early-phase trial data and precision-oncology biomarkers with keen interest. His writing helps clinicians keep pace with a fast-moving field.
Published Work
Recent Clinical Updates
28 articles
Oncology
FDA Approves Capivasertib for PTEN‑Deficient mAPMN/S: 7.5‑mo rPFS
Capivasertib FDA approval for PTEN‑deficient mAPMN/S prostate cancer: 7.5‑month rPFS gain in CAPItello‑281; selection by PTEN testing and glucose monitoring required.
Oncology
tafasitamab-cxix: FDA Approves for Relapsed/Refractory Follicular Lymphoma — PFS HR 0.43 in inMIND
tafasitamab-cxix (Monjuvi) FDA approval for relapsed/refractory follicular lymphoma; inMIND: PFS HR 0.43; ORR 84% vs 72% — dosing and safety details.
Oncology
FDA Approves Pembrolizumab for High-Risk Early-Stage TNBC: 63% pCR in KEYNOTE-522
FDA approves pembrolizumab for high-risk early-stage TNBC: 63% pCR in KEYNOTE-522 trial.
Oncology
Zilovertamab Vedotin Shows Promising Results in CLL: 40% ORR in Phase II Trial
Zilovertamab vedotin shows 40% ORR in CLL, highlighting ADC potential in oncology.
Oncology
Intismeran Autogene Cuts Melanoma Relapse 49% at 5 Years
Intismeran autogene reduces melanoma recurrence by 49% at five years, providing significant implications for treatment in stage III melanoma.
Oncology
Harnessing mRNA Vaccine Technology: A New Frontier in Cancer Immunotherapy
Explore the potential of mRNA vaccines in cancer immunotherapy, highlighting advancements and clinical implications for patient care.
Pharmaceutical Research
AI-Powered Drug Discovery: Transforming Treatment for Rare Diseases
Explore how AI is transforming drug discovery for rare diseases, improving efficiency and patient outcomes in pharmaceutical research.
Oncology
Talotrectinib Receives FDA Approval for ROS1+ NSCLC: A New Era in Targeted Therapy
Talotrectinib approved for ROS1+ NSCLC, offering new hope with high response rates and favorable safety profile.
Health Information
Boost Orthodontic Success with Proper Oral Hygiene
Learn how to maintain dental health during orthodontic treatment and prevent complications for a successful outcome and healthy smile.
Oncology
Reduce EGFRm NSCLC Dermatologic Toxicities by 30%
Proactive management approaches can minimize EGFR-related skin toxicities, improving quality of life for NSCLC patients on chemotherapy-free regimens.
Oncology
Triples Therapy Boosts PFS in ES-SCLC Maintenance
Discover how a triplet regimen improves progression-free survival in extensive-stage small cell lung cancer patients, enhancing maintenance therapy outcomes.
Oncology
ctDNA Surveillance Cuts CRC Recurrence Risk
New data reveals 80% of ctDNA-positive CRC patients experience molecular recurrence within 12-15 months, highlighting need for ongoing surveillance and potential early resistance t...
Oncology
Cut Ovarian Cancer Detection Costs with Risk-Based Triage
Improve ovarian cancer detection in primary care with cost-effective risk-based triage strategies, reducing unnecessary tests and improving patient outcomes.
Medical Research
Biodegradable Sensors Cut Waste, Enhance Wearable Tech
Discover how sustainable wearable health sensors made from seafood waste can improve patient care and reduce environmental impact with biodegradable materials.
Oncology
Improve Ovarian Cancer Detection with CA125 & Age-Based Models
Enhance primary care diagnosis with validated CA125 and age-based models, reducing late-stage ovarian cancer presentations and improving patient outcomes.
Oncology
BRAF-Mutant Thyroid Cancer Treatment Yields 63.9-Month PFS
Discover how a new treatment approach for BRAF-mutant thyroid cancer achieves durable clinical efficacy and a favorable safety profile in clinical trials.
Medical Research
Kidney Lymphatics Disrupted in Chronic Rejection
Discover how lymphatic architecture changes in chronic transplant rejection, impacting kidney function and patient outcomes in medical research studies.
Medical Research
28% of Adults Struggle with Post-Pandemic Mental Health
Nearly 1 in 3 people face difficulties adjusting to life after COVID-19, a new study reveals key emotional and cognitive factors affecting recovery.
Medical Research
Boost Memory in Alzheimer's Patients with Exercise
Discover how physical activity improves cognitive function in Alzheimer's disease, a neurodegenerative condition affecting millions worldwide, and learn strategies to slow its prog...
Oncology
Minimize Immune-Related AEs in Kidney Cancer Therapy
Learn strategies to overcome immune-related toxicities in renal cell carcinoma treatment and potentially improve patient outcomes.
Healthcare Business
Flu Hospitalizations Surge 30% Above Decade Average
US flu hospitalizations reach highest levels in over a decade, impacting healthcare systems and patient care, according to CDC's latest report and data analysis.
Oncology
New Option for Platinum-Resistant Ovarian Cancer
Breakthrough therapy designation granted for treatment of adult patients with platinum-resistant epithelial ovarian cancer, offering new hope for previously treated patients.
Oncology
Boost Kidney Cancer Treatment with Genetic Insights
Learn how understanding somatic alterations can improve kidney cancer treatment outcomes and patient responses to therapy, from a leading oncology expert.
Oncology
Boost NSCLC Outcomes with TTFields
Improve treatment for unresectable advanced/recurrent NSCLC with a new approved therapy, enhancing patient outcomes and care.
Oncology
33% Response Rate in R/R AML with Single-Agent Therapy
New trial results show promising response rates in relapsed/refractory NPM1-mutant AML, offering potential new treatment options for patients.
Medical Research
Boost Muscle Growth 25% with Right Protein Source
Discover how different high-protein animal foods impact muscle-building response to weight training, and optimize your patients' nutrition plans accordingly.
Medical Research
AI Models Identify 30% More Effective Antibodies
Improve antibody development efficiency by training AI models on negative data to identify effective antibodies and reduce costly experiments.
Biomedical Research
Epigenome and Longevity Research
Discover how epigenome changes promote longevity and are passed to offspring through parental cells.